Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 6 studies | 42% ± 23% | |
GABAergic neuron | 6 studies | 41% ± 19% | |
retinal cone cell | 4 studies | 22% ± 4% | |
astrocyte | 4 studies | 23% ± 7% | |
adipocyte | 4 studies | 19% ± 4% | |
interneuron | 4 studies | 43% ± 22% | |
endothelial cell | 3 studies | 28% ± 6% | |
epithelial cell | 3 studies | 27% ± 11% | |
retinal rod cell | 3 studies | 21% ± 3% | |
oligodendrocyte precursor cell | 3 studies | 20% ± 3% | |
transit amplifying cell | 3 studies | 34% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 562.63 | 1443 / 1445 | 99% | 9.49 | 182 / 183 |
ovary | 100% | 462.14 | 180 / 180 | 99% | 7.26 | 425 / 430 |
stomach | 100% | 527.99 | 359 / 359 | 98% | 6.94 | 281 / 286 |
intestine | 100% | 494.34 | 963 / 966 | 98% | 7.20 | 518 / 527 |
brain | 100% | 698.73 | 2632 / 2642 | 98% | 6.34 | 689 / 705 |
breast | 100% | 439.79 | 458 / 459 | 97% | 7.58 | 1084 / 1118 |
prostate | 100% | 434.87 | 245 / 245 | 96% | 6.67 | 483 / 502 |
uterus | 99% | 407.25 | 169 / 170 | 95% | 6.98 | 435 / 459 |
bladder | 100% | 413.14 | 21 / 21 | 94% | 6.01 | 472 / 504 |
lung | 96% | 296.40 | 552 / 578 | 98% | 6.58 | 1130 / 1155 |
thymus | 100% | 657.81 | 653 / 653 | 90% | 4.66 | 545 / 605 |
kidney | 100% | 1173.01 | 89 / 89 | 88% | 6.71 | 791 / 901 |
skin | 100% | 789.48 | 1809 / 1809 | 83% | 4.83 | 393 / 472 |
liver | 100% | 668.56 | 226 / 226 | 80% | 3.93 | 323 / 406 |
pancreas | 100% | 358.63 | 327 / 328 | 79% | 3.36 | 140 / 178 |
adrenal gland | 99% | 442.05 | 255 / 258 | 72% | 3.42 | 165 / 230 |
muscle | 100% | 1038.32 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 245.55 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.12 | 1 / 1 |
adipose | 100% | 402.05 | 1198 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 322.09 | 1323 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 7.42 | 42 / 45 |
heart | 91% | 476.32 | 781 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 79% | 3.77 | 23 / 29 |
eye | 0% | 0 | 0 / 0 | 41% | 1.43 | 33 / 80 |
peripheral blood | 23% | 320.90 | 210 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006103 | Biological process | 2-oxoglutarate metabolic process |
GO_0044281 | Biological process | small molecule metabolic process |
GO_0016020 | Cellular component | membrane |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0047545 | Molecular function | 2-hydroxyglutarate dehydrogenase activity |
Gene name | L2HGDH |
Protein name | L-2-hydroxyglutarate dehydrogenase L-2-hydroxyglutarate dehydrogenase, mitochondrial (EC 1.1.99.2) L-2-hydroxyglutarate dehydrogenase, mitochondrial (EC 1.1.99.2) (Duranin) |
Synonyms | C14orf160 |
Description | |
Accessions | ENST00000421284.7 [Q9H9P8-1] C9JVN9 G3V5S1 G3V3E2 Q9H9P8 ENST00000267436.9 [Q9H9P8-1] ENST00000555423.5 ENST00000554191.5 G3V272 ENST00000261699.8 ENST00000555610.1 |